Publication Cover
Biofouling
The Journal of Bioadhesion and Biofilm Research
Volume 32, 2016 - Issue 1
1,860
Views
2
CrossRef citations to date
0
Altmetric
Articles

Growth of MRSA and Pseudomonas aeruginosa in a fine-celled foam model containing sessile commensal skin bacteria

&
Pages 25-33 | Received 26 Aug 2015, Accepted 04 Nov 2015, Published online: 04 Jan 2016

References

  • Agostinho AM, Hartman A, Lipp C, Parker AE, Stewart PS, James GA. 2011. An in vitro model for the growth and analysis of chronic wound MRSA biofilms. J Appl Microbiol. 111:1275–1282. doi:10.1111/jam.2011.111.issue-5
  • Al-Bakri AG, Gilbert P, Allison DG. 2004. Immigration and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities. J Appl Microbiol. 96:455–463. doi:10.1111/jam.2004.96.issue-3.
  • Axelsson L, Mahida Y. 2000. Flora: role in colonisation resistance and other effects; production of antimicrobial peptides. Microb Ecol Health Dis. 12;1 supp 2:216 –422.
  • Barnea Y, Weiss J, Gur E. 2010. A review of the applications of the hydrofiber dressing with silver (Aquacel Ag(®)) in wound care. Ther Clin Risk Manag. 6:21–27.
  • Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, Hoiby N, Givskov M. 2008. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen. 16:2–10. doi:10.1111/wrr.2008.16.issue-1.
  • Charles CA, Ricotti CA, Davis SC, Mertz PM, Kirsner RS. 2009. Use of tissue-engineered skin to study in vitro biofilm development. Dermatol Surg. 35:1334–1341. doi:10.1111/j.1524-4725.2009.01238.x.
  • Dalton T, Dowd SE, Wolcott RD, Sun Y, Watters C, Griswold JA, Rumbaugh KP. 2011. An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS one. 6:e27317. doi:10.1371/journal.pone.0027317.
  • Dowd S, Sun Y, Secor P, Rhoads D, Wolcott B, James G, Wolcott R. 2008. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol. 8:43. doi:10.1186/1471-2180-8-43.10.1186/1471-2180-8-43
  • Dowd SE, Sun Y, Smith E, Kennedy JP, Jones CE, Wolcott R. 2009. Effects of biofilm treatments on the multi-species Lubbock chronic wound biofilm model. J Wound Care. 18(508):510–512.
  • Fredricks DN. 2001. Microbial ecology of human skin in health and disease. J Investig Dermatol Symp Proc. 6:167–169. doi:10.1046/j.0022-202x.2001.00039.x.
  • Gander S, Hayward K, Finch R. 2002. An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. J. Antimicrob. Chemother. 49:301–308.
  • Haisma EM, Rietveld MH, de Breij A, van Dissel JT, El Ghalbzouri A, Nibbering PH. 2013. Inflammatory and antimicrobial responses to methicillin-resistant staphylococcus aureus in an in vitro wound infection model. PLoS one. 8:e82800. doi:10.1371/journal.pone.0082800.
  • Hammond AA, Miller KG, Kruczek CJ, Dertien J, Colmer-Hamood JA, Griswold JA, Horswill AR, Hamood AN. 2011. An in vitro biofilm model to examine the effect of antibiotic ointments on biofilms produced by burn wound bacterial isolates. Burns. 37:312–321. doi:10.1016/j.burns.2010.09.017.
  • Hill KE, Malic S, McKee R, Rennison T, Harding KG, Williams DW, Thomas DW. 2010. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J Antimicrob Chemother. 65:1195–1206. doi:10.1093/jac/dkq105.
  • Humphreys G, Lee GL, Percival SL, McBain AJ. 2011. Combinatorial activities of ionic silver and sodium hexametaphosphate against microorganisms associated with chronic wounds. J Antimicrob Chemother. 66:2556–2561. doi:10.1093/jac/dkr350.
  • Inniss WE, Mayfield CI. 1978. Growth rates of psychrotrophic sediment microorganisms. Water Res. 12(4):231–236. doi:10.1016/0043-1354(78)90091-X.
  • James G, Swogger E, Wolcott R, deLancey-Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS. 2008. Biofilms in chronic wounds. Wound Repair Regen. 16:37–44. doi:10.1111/wrr.2008.16.issue-1.
  • Kinniment SL, Wimpenny JWT, Adams D, Marsh PD. 1996. Development of a steady-state oral microbial biofilm community using the constant-depth film fermenter. Microbiology. 142:631–638. doi:10.1099/13500872-142-3-631.
  • Kostenko V, Lyczak J, Turner K, Martinuzzi RJ. 2010. Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob Agents Chemother. 54:5120–5131. doi:10.1128/AAC.00825-10.
  • Kucera J, Sojka M, Pavlik V, Szuszkiewicz K, Velebny V, Klein P. 2014. Multispecies biofilm in an artificial wound bed—A novel model for in vitro assessment of solid antimicrobial dressings. J Microbiol Meth. 103:18–24. doi:10.1016/j.mimet.2014.05.008.
  • Ledder RG, Madhwani T, Sreenivasan PK, De Vizio W, McBain AJ. 2009. An in vitro evaluation of hydrolytic enzymes as dental plaque control agents. J Med Microbiol. 58:482–491. doi:10.1099/jmm.0.006601-0.
  • Lenski RE, Rose MR, Simpson SC, Tadler SC. 1991. Long-term experimental evolution in Escherichia coli. 1. Adaptation and divergence during 2,000 generations. Am Soc Nat. 138:1315–1341. doi:10.1086/an.1991.138.issue-6.
  • Lipp C, Kirker K, Agostinho A, James G, Stewart P. 2010. Testing wound dressings using an in vitro wound model. J Wound Care. 19:220–226. doi:10.12968/jowc.2010.19.6.48468.
  • Malic S, Hill KE, Hayes A, Percival SL, Thomas DW, Williams DW. 2009. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology. 155:2603–2611. doi:10.1099/mic.0.028712-0.
  • Matejka KM, Bremer PJ, Tompkins GR, Brooks HJL. 2012. Antibiotic susceptibility of Moraxella catarrhalis biofilms in a continuous flow model. Diagn Microbiol Infect Dis. 74:394–398. doi:10.1016/j.diagmicrobio.2012.08.021.
  • McAuliffe O, Ross RP, Hill C. 2001. Lantibiotics: structure, biosynthesis and mode of action. Fems Microbiol Rev. 25:285–308. doi:10.1111/j.1574-6976.2001.tb00579.x.
  • McBain AJ. 2009. Chapter 4 In vitro biofilm models: an overview. Adv Appl Microbiol. 69:99–132. doi:10.1016/S0065-2164(09)69004-3.
  • McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG, Gilbert P. 2003a. Growth and molecular characterization of dental plaque microcosms. J Appl Microbiol. 94:655–664. doi:10.1046/j.1365-2672.2003.01876.x.
  • McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG, Rickard AH, Symmons SA, Gilbert P. 2003. Microbial characterization of biofilms in domestic drains and the establishment of stable biofilm microcosms. Appl Environ Microbiol. 69:177–185. doi:10.1128/AEM.69.1.177-185.2003.
  • McBain AJ, Ledder RG, Moore LE, Catrenich CE, Gilbert P. 2004. Effects of quaternary-ammonium-based formulations on bacterial community dynamics and antimicrobial susceptibility. Appl Environ Microbiol. 70:3449–3456. doi:10.1128/AEM.70.6.3449-3456.2004.
  • Oates A, Bowling FL, Boulton AJM, Bowler PG, Metcalf DG, McBain AJ. 2014. The visualization of biofilms in chronic diabetic foot wounds using routine diagnostic microscopy methods. J Diabetes Res. 2014:8. doi:10.1155/2014/153586.
  • Pratten J, Smith AW, Wilson M. 1998. Response of single species biofilms and microcosm dental plaques to pulsing with chlorhexidine. J Antimicrob Chemother. 42:453–459. doi:10.1093/jac/42.4.453.
  • Rozen DE, McGee L, Levin BR, Klugman KP. 2007. Fitness costs of fluoroquinolone resistance in streptococcus pneumoniae. Antimicrob Agents Chemother. 51:412–416. doi:10.1128/AAC.01161-06.
  • Russell R, Wiles CM. 1970. Documenta Geigy Scientific Tables. 7th ed. Ciba-Geigy Ltd.
  • Steffansen B, Herping SPK. 2008. Novel wound models for characterizing ibuprofen release from foam dressings. Int J Pharm. 364:150–155. doi:10.1016/j.ijpharm.2008.07.025.
  • Sun Y, Dowd SE, Smith E, Rhoads DD, Wolcott RD. 2008. In vitro multispecies Lubbock chronic wound biofilm model. Wound Repair Regen. 16:805–813. doi:10.1111/j.1524-475X.2008.00434.x.
  • Taylor B, Greenman J. 2010. Modelling the effects of pH on tongue biofilm using a sorbarod biofilm perfusion system. J Breath Res. 4:017107. doi:10.1088/1752-7155/4/1/017107.
  • Thorn RMS, Greenman J. 2009. A novel in vitro flat-bed perfusion biofilm model for determining the potential antimicrobial efficacy of topical wound treatments. J Appl Microbiol. 107:2070–2079. doi:10.1111/jam.2009.107.issue-6.
  • Trengove, Langton. 1996. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen. 4:234–239. doi:10.1046/j.1524-475X.1996.40211.x.
  • Varella Coelho ML, Santos Nascimento JD, Fagundes PC, Madureira DJ, Oliveira SSD, de Paiva Vasconcelos, Brito MA, Freire Bastos MDCD. 2007. Activity of staphylococcal bacteriocins against Staphylococcus aureus and Streptococcus agalactiae involved in bovine mastitis. Res Microbiol. 158:625–630. doi:10.1016/j.resmic.2007.07.002.
  • Woods J, Boegli L, Kirker KR, Agostinho AM, Durch AM, deLancey Pulcini E, Stewart PS, James GA. 2012. Development and application of a polymicrobial, in vitro, wound biofilm model. J Appl Microbiol. 112:998–1006. doi:10.1111/jam.2012.112.issue-5.
  • Wright E, Neethirajan S, Weng X. 2015. Microfluidic wound model for studying the behaviors of Pseudomonas aeruginosa in polymicrobial biofilms. Biotechnol Bioeng. 112:2351–2359. doi:10.1002/bit.v112.11.
  • Yang Q, Phillips PL, Sampson EM, Progulske-Fox A, Jin S, Antonelli P, Schultz GS. 2013. Development of a novel ex vivo porcine skin explant model for the assessment of mature bacterial biofilms. Wound Repair Regen. 21:704–714. doi:10.1111/wrr.12074.